An article that reviews the current understanding and management of Gastro-Oesophageal Reflux Disease(GORD) and Non-Ulcer Dyspepsia (NUD). It discusses the progress made in surgeries implementing best practice guidelines with strategies to step-down and/or step-off acid suppression medication. The role of an alginate reflux suppressant to manage breakthrough symptoms and maintain patients at the lowest effective dose of PPI medication is described.

The production of this article was sponsored by Reckitt Benckiser and can be accessed by clicking here

The article is available to registered users. Registration is a quick process and gives instant access to additional areas of the site - register here.